1-6 of 6
Françoise Kraeber bodere
Close
Sort by
Journal Articles

Consolidation Anti-CD22 Fractionated Radioimmunotherapy with 90 y-Epratuzumab Tetraxetan Following R-CHOP in Elderly DLBCL Patients: A Lysa Phase II Prospective Trial

Françoise Kraeber-Bodere, MD, PhD, Amandine Pallardy, MD, Steven Le Gouill, Hervé Maisonneuve, MD, Thierry Lamy, MD, Krimo Bouabdallah, MD, Noel Milpied, MD, Henry Jardel, MD, Eric Deconinck, MD, PhD, Nadine Morineau, MD, Charles Foussard, MD, Annie Brion, MD, Remy Gressin, MD, Olivier Tournilhac, MD, PhD, Emmanuel Gyan, MD, PhD, Anne Moreau, MD, Christian Berthou, MD, Francois Dreyfus, Caroline Bodet-Milin, MD, Anne-Laure Cazeau, MD, Etienne Garin, MD, PhD, Jean-Philippe Vuillez, MD, PhD, Loic Campion, MD, Philippe Moreau, MD, William A Wegener, MD, PhD, David M Goldenberg, ScD, MD, Pierre Soubeyran, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 906.
https://doi.org/10.1182/blood.V120.21.906.906
Published: 2012
Journal Articles

Fractionated 90 y Ibritumomab Tiuxetan (Zevalin™) Radioimmunotherapy As An Initial Therapy of Follicular Lymphoma – First Results From a Phase II Study in Patients Requiring Treatment According to GELF/BNLI Criteria

Timothy M Illidge, MD, PhD, Ruth Pettengell, MD, Michael Bayne, MD, Steven Le Gouill, MD, PhD, Andrew Bates, MD, John Radford, MD, Jill Tipping, PhD, Maureen Zivanovic, PhD, Françoise kraeber-Bodere, MD, Emmanuel Malek, PhD, Huglo Damien, MD, Franck Morschhauser, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 102.
https://doi.org/10.1182/blood.V118.21.102.102
Published: 2011
Journal Articles

Consolidation Anti-CD22 Fractionated Radioimmunotherapy with 90Y Epratuzumab Tetraxetan Following R-CHOP In Elderly DLBCL Patients

Françoise kraeber-Bodere, Hervé Maisonneuve, MD, Thierry Lamy, Steven Le Gouill, Eric Deconninck, MD, Amandine Pallardy, Caroline bodet-Milin, Noel Milpied, MD, Nadine Morineau, MD, Charles Foussard, MD, Thomas Gastinne, Remy Gressin, MD, Olivier Tournilhac, MD, PhD, Emmanuel Gyan, MD, PhD, Anne Moreau, Alain Faivre-Chauvet, Anne-Laure Cazeau, Etienne Garin, Jean-Philippe Vuillez, Jean-François Chatal, Jean-Luc Harousseau, Philippe Moreau, William Wegener, MD, PhD, David Goldenberg, Pierre Soubeyran, MD
Journal: Blood
Blood (2010) 116 (21): 2875.
https://doi.org/10.1182/blood.V116.21.2875.2875
Published: 2010
Journal Articles

Respective PROGNOSTIC Value of the International Harmonization PROJECT (IHP), Gallamini and London Criteria for Interim FDG PET-CT Performed AFTER 4 Courses of ABVD IN HODGKIN'S LYMPHOMA

Thomas Gastinne, Pierre-yves Le roux, Caroline bodet-Milin, Beatrice Mahe, Viviane Dubruille, Nicolas Blin, Nadine Morineau, MD, Herve Maisonneuve, MD, Anne Moreau, Philippe Moreau, Jean-Luc Harousseau, Pierre-Yves Salaun, Françoise kraeber-Bodere, Steven Le Gouill
Journal: Blood
Blood (2010) 116 (21): 3889.
https://doi.org/10.1182/blood.V116.21.3889.3889
Published: 2010
Journal Articles

Prognosis Value of [ 18 f] FDG-PET Prior Versus after Autologous Stem Cells Transplantation in High Grade Non-Hodgkin’s Lymphoma.

Virginie Roland, Caroline Bodet Milin, Anne Moreau, Thomas Gastinne, Beatrice Mahe, Viviane Dubruille, Hervé Maisonneuve, Nadine Morineau, Philippe Moreau, Henri Jardel, Lucie Planche, Philippe Moreau, Jean- Luc Harousseau, Françoise Kraeber bodere, Steven Le Gouill, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2177.
https://doi.org/10.1182/blood.V112.11.2177.2177
Published: 2008
Journal Articles

Efficacy of FDG-PET/CT Imaging To Guide Biopsies in the Detection of Richter’s Syndrome.

Steven Le Gouill, MD, PhD, Caroline Bodet-Milin, MD, Françoise Kraeber-Bodere, MD, PhD, Anne Moreau, MD, Laurent Campion, Benoit Dupas, MD, Thomas Gastinne, MD, Philippe Moreau, MD, Jean-Luc Harousseau, MD
Journal: Blood
Blood (2007) 110 (11): 1390.
https://doi.org/10.1182/blood.V110.11.1390.1390
Published: 2007